Induction of collagenolytic and proteolytic activities by anti-inflammatory drugs in the skin and fibroblast.
D000818:Animals; D003094:Collagen / Q000378:metabolism*; D046508:Culture Techniques; D003513:Cycloheximide / Q000494:pharmacology; D003609:Dactinomycin / Q000494:pharmacology; D003864:Depression, Chemical; D004790:Enzyme Induction; D005347:Fibroblasts / Q000187:drug effects / Q000201:enzymology*; D005966:Glucuronidase / Q000378:metabolism; D006854:Hydrocortisone / Q000494:pharmacology*; D007213:Indomethacin / Q000494:pharmacology*; D008297:Male; D003012:Microbial Collagenase / Q000096:biosynthesis*; D010113:Oxyphenbutazone / Q000494:pharmacology*; D010447:Peptide Hydrolases / Q000096:biosynthesis*; D010672:Phenytoin / Q000494:pharmacology; D011691:Puromycin / Q000494:pharmacology; D012313:RNA / Q000378:metabolism; D051381:Rats; D012867:Skin / Q000166:cytology / Q000201:enzymology*; D013268:Stimulation, Chemical
D003609:Dactinomycin; D011691:Puromycin; D010672:Phenytoin; D012313:RNA; D003094:Collagen; D003513:Cycloheximide; D005966:Glucuronidase; D010447:Peptide Hydrolases; D003012:Microbial Collagenase; D010113:Oxyphenbutazone; D006854:Hydrocortisone; D007213:Indomethacin